Although their track record is one of over-promising and under-delivering, even companies delivering on their promises have taken a severe beating of late - take a look at DIO for example.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025